Antigen-specific activation of gut immune cells drives autoimmune neuroinflammation.

Microbiome-based therapies are promising new treatment avenues. While global alterations in microbiota composition have been shown in multiple sclerosis, whether and how gut microbiota influence autoimmune responses in an antigen-specific manner is unclear. Here, we genetically engineered gut bacteria to express a brain antigen and dissect their pathogenic potential in a murine model of autoimmune neuroinflammation. Colonization with bacteria expressing myelin - but not ovalbumin-peptide exacerbates an encephalitogenic immune response in the gut by activating antigen-specific T cells as well as B cells leading to accelerated neuroinflammatory disease. These results demonstrate how antigen-specific microbial modulation can influence autoimmunity, providing insight for development of therapeutic strategies targeting specific bacterial taxa for treatment of MS and other autoimmune diseases.

Authors

Institutions

Publication Details

Journal
Open Access CRIS of the University of Bern
Published
2025-12-31
DOI
https://doi.org/10.48620/93637
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antigen-specific activation of gut immune cells drives autoimmune neuroinflammation.

Kristina Berve, David Schreiner, Julia Dyckow, Sharon A. Sagan et al.
Open Access CRIS of the University of Bern
Gut microbiota and health
article

Antigen-specific activation of gut immune cells drives autoimmune neuroinflammation.

Kristina Berve, David Schreiner, Julia Dyckow, Sharon A. Sagan, Joseph J. Sabatino, Amel Zulji, Stephanie C. Ganal‐Vonarburg, Lena K. Siewert, Aida Muñoz-Blázquez, Lucas Schirmer, Ryan Baumann, Elisabeth Pössnecker, Kazuki Nagashima, Scott Zamvil, Anne-Katrin Pröbstel, Médéric Diard, Andrew J. Macpherson, Sergio E Baranzini, Gurumoorthy Krishnamoorthy, Michael A Fischbach, Charlotte Nelson
article en

Abstract

Microbiome-based therapies are promising new treatment avenues. While global alterations in microbiota composition have been shown in multiple sclerosis, whether and how gut microbiota influence autoimmune responses in an antigen-specific manner is unclear. Here, we genetically engineered gut bacteria to express a brain antigen and dissect their pathogenic potential in a murine model of autoimmune neuroinflammation. Colonization with bacteria expressing myelin - but not ovalbumin-peptide exacerbates an encephalitogenic immune response in the gut by activating antigen-specific T cells as well as B cells leading to accelerated neuroinflammatory disease. These results demonstrate how antigen-specific microbial modulation can influence autoimmunity, providing insight for development of therapeutic strategies targeting specific bacterial taxa for treatment of MS and other autoimmune diseases.

Open Access CRIS of the University of Bern
Tracer Technologies (United States) (US)
Good health and well-being
Openalex Percentile: Top 35%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.